SGMOQ

0.10601.94%
SB

Scott B. Willoughby

Senior VP, Chief Legal Officer & Corporate Secretary

Mr. Scott B. Willoughby is Corporate Secretary of Sangamo Therapeutics, Inc. from August 2021 and serves as its Senior Vice President from August 2021 and has been its Chief Legal Officer since 2025 and had been its General Counsel until 2025. Mr. Willoughby joined Sangamo in March 2020 as Vice President and Head of Corporate Law. Previously, Mr. Willoughby served as Vice President, Deputy General Counsel from February 2019 to July 2019 and as Associate General Counsel, Corporate & Compliance from September 2017 to February 2019, at Achaogen, Inc. From February 2016 to September 2017, Mr. Willoughby served as Senior Counsel, M&A at McKesson Corporation. Earlier in his career, Mr. Willoughby held several senior counsel roles where he built his expertise in corporate governance, SEC reporting, corporate finance, compliance, M&A and international expansion. Mr. Willoughby received a B.A. and J.D. from the University of California, Berkeley.

Positions